- Primary dysmenorrhea occurs in the absence of pelvic pathology
- Secondary dysmenorrhea occurs in the presence of pelvic pathology.
Summary
Primary dysmenorrhea
Secondary dysmenorrhea
Library
Citations
Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017 Jul;39(7):585-95.[Abstract]
ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec (Re-affirmed 2021);132(6):1517-8. [Abstract][Full Text]
Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020 Jan 21;323(3):268-9.[Abstract]
1. Fernández-Martínez E, Onieva-Zafra MD, Parra-Fernández ML. The impact of dysmenorrhea on quality of life among Spanish female university students. Int J Environ Res Public Health. 2019 Feb 27;16(5):713.[Abstract][Full Text]
2. Iacovides S, Avidon I, Bentley A, et al. Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea. Acta Obstet Gynecol Scand. 2014 Feb;93(2):213-7.[Abstract][Full Text]
3. Al-Jefout M, Seham AF, Jameel H, et al. Dysmenorrhea: prevalence and impact on quality of life among young adult Jordanian females. J Pediatr Adolesc Gynecol. 2015 Jun;28(3):173-85.[Abstract]
4. Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015;21:762-78.[Abstract]
5. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134-1138.[Abstract]
6. Burnett M, Lemyre M. No. 345-Primary Dysmenorrhea Consensus Guideline. J Obstet Gynaecol Can. 2017 Jul;39(7):585-95.[Abstract]
7. Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36:104-13.[Abstract][Full Text]
8. Latthe P, Latthe M, Say L, et al. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006 Jul 6;6:177.[Abstract][Full Text]
9. Harlow SD, Ephross SA. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev. 1995;17(2):265-86.[Abstract]
10. Kennedy S. Primary dysmenorrhoea. Lancet. 1997 Apr 19;349(9059):1116.[Abstract]
11. Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG. 2010 Jan;117(2):185-92.[Abstract][Full Text]
12. Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. J Obstet Gynaecol Can. 2005;27:765-770.[Abstract]
13. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol. 1996;103:1134-42.[Abstract]
14. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol. 1990;97:588-594.[Abstract]
15. Chen CX, Draucker CB, Carpenter JS. What women say about their dysmenorrhea: a qualitative thematic analysis. BMC Womens Health. 2018 Mar 2;18(1):47.[Abstract][Full Text]
16. Gray TG, Moores KL, James E, et al. Development and initial validation of an electronic personal assessment questionnaire for menstrual, pelvic pain and gynaecological hormonal disorders (ePAQ-MPH). Eur J Obstet Gynecol Reprod Biol. 2019 Jul;238:148-156.[Abstract]
17. ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018 Dec (Re-affirmed 2021);132(6):1517-8. [Abstract][Full Text]
18. Hirsch M, Dhillon-Smith R, Cutner AS, et al. The prevalence of endometriosis in adolescents with pelvic pain: a systematic review. J Pediatr Adolesc Gynecol. 2020 Dec;33(6):623-30.[Abstract][Full Text]
19. Dawood MY. Dysmenorrhea. Clin Obstet Gynecol. 1990;33:168-178.[Abstract]
20. Lumsden MA, Baird DT. Intra-uterine pressure in dysmenorrhea. Acta Obstet Gynecol Scand. 1985;64:183-186.[Abstract]
21. Altunyurt S, Göl M, Altunyurt S, et al. Primary dysmenorrhea and uterine blood flow: a color Doppler study. J Reprod Med. 2005;50:251-255.[Abstract]
22. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:428-441.[Abstract]
23. Lumsden MA, Kelly RW, Baird DT. Primary dysmenorrhoea: the importance of both prostaglandin E2 and F2 alpha. Br J Obstet Gynaecol. 1983;90:1135-1140.[Abstract]
24. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol. 1979;135:102-108.[Abstract]
25. Eden JA. Dysmenorrhea and premenstrual syndrome. In: Hacker NF, Moore JG, eds. Essentials of obstetrics and gynecology. 3rd edition. Philadelphia: WB Saunders; 1998.
26. Hedenberg-Magnusson B, Ernberg M, Alstergren P, et al. Pain mediation by prostaglandin E2 and leukotriene B4 in the human masseter muscle. Acta Ondontol Scand. 2001;59:348-355.[Abstract]
27. Akerlund M, Stromberg P, Forsling ML. Primary dysmenorrhoea and vasopressin. Br J Obstet Gynaecol. 1979;86:484-487.[Abstract]
28. Liedman R, Hansson SR, Howe D, et al. Endometrial expression of vasopressin, oxytocin and their receptors in patients with primary dysmenorrhoea and healthy volunteers at ovulation. Eur J Obstet Gynecol Reprod Biol. 2008;137:189-192.[Abstract]
29. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 110: noncontraceptive uses of hormonal contraceptives. Obstet Gynecol. 2010;115:206-218.[Abstract]
30. Wong CL, Farquhar C, Roberts H, et al. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002120.[Abstract][Full Text]
31. Marjoribanks J, Ayeleke RO, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2015 Jul 30;(7):CD001751.[Abstract][Full Text]
32. Low I, Wei SY, Lee PS, et al. Neuroimaging Studies of Primary Dysmenorrhea. Adv Exp Med Biol. 2018;1099:179-99.[Abstract]
33. Wu MH, Shoji Y, Chuang PC, et al. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med. 2007;9:1-20.[Abstract]
34. Nelson AL, Massoudi N. New developments in intrauterine device use: focus on the US. Open Access J Contracept. 2016;7:127-141.[Abstract][Full Text]
35. Imai A, Matsunami K, Takagi H, et al. Levonorgestrel-releasing intrauterine device used for dysmenorrhea: five-year literature review. Clin Exp Obstet Gynecol. 2014;41(5):495-8.[Abstract]
36. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. Aug 2023 [internet publication].[Full Text]
37. Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001439.[Abstract][Full Text]
38. Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies. Expert Opin Pharmacother. 2008;9:2661-72.[Abstract]
39. Fothergill DJ. Common menstrual problems in adolescence. Arch Dis Child Educ Pract Ed. 2010;95:199-203.[Abstract]
40. Kho KA, Shields JK. Diagnosis and management of primary dysmenorrhea. JAMA. 2020 Jan 21;323(3):268-9.[Abstract]
41. Saad Amer. Endometriosis. Obstetrics, Gynaecology and Reproductive Medicine. 2008;18:126-133.
42. Bettendorf B, Shay S, Tu F. Dysmenorrhea: contemporary perspectives. Obstet Gynecol Surv. 2008;63:597-603.[Abstract]
43. Latthe P, Mignini L, Gray R, et al. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006;332:749-755.[Abstract][Full Text]
44. Chapron C, Dubuisson JB, Pansini V, et al. Routine clinical examination is not sufficient for diagnosing and locating deeply infiltrating endometriosis. J Am Assoc Gynecol Laparosc. 2002;9:115-119.[Abstract]
45. Durain D. Primary dysmenorrhea: assessment and management update. J Midwifery Womens Health. 2004;49:520-528.[Abstract]
46. British Association for Sexual Health and HIV (BASHH). United Kingdom National Guideline for the Management of Pelvic Inflammatory Disease. 2019 [internet publication].[Full Text]
47. Howard FM. The role of laparoscopy as a diagnostic tool in chronic pelvic pain. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14:467-94.[Abstract]
48. Goller JL, De Livera AM, Fairley CK, et al. Population attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data. Sex Transm Infect. 2016 Nov;92(7):525-31.[Abstract][Full Text]
49. Price MJ, Ades AE, Welton NJ, et al. Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods. J Infect Dis. 2016 Aug 15;214(4):617-24.[Abstract][Full Text]
Key Articles
Referenced Articles
Sign in to access our clinical decision support tools